• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    SELLAS Life Sciences Group, Inc. - Common Stock (NQ:SLS)

    12.90 +0.43 (+3.41%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Jul 21, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 5,084,129
    Open 12.56
    Bid (Size) 12.87 (2,000)
    Ask (Size) 12.90 (5,000)
    Prev. Close 12.47
    Today's Range 12.22 - 13.24
    52wk Range 1.390 - 15.88
    Shares Outstanding 15,873,941
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    SELLAS Stock Hits New Highs: What's Happening Today? ↗
    SELLAS Life Sciences Group Inc (NASDAQ: SLS) shares are pushing higher Friday morning, extending Thursday’s strong rally. 
    Via Benzinga
    Stay updated with the stocks that are on the move in today's pre-market session. ↗
    Via Chartmill

    Performance

    YTD
    +196.6%
    +196.6%
    1 Month
    +51.2%
    +51.2%
    3 Month
    +158.5%
    +158.5%
    6 Month
    +198.6%
    +198.6%
    1 Year
    +597.3%
    +597.3%

    More News

    Read More
    These stocks are moving in today's after hours session ↗
    Via Chartmill
    News headline image
    SLS Stock Jumps Overnight: ‘Potent’ AML Drug Data Ahead Of Cancer Summit Fuels Fresh Momentum ↗
    Via Stocktwits
    SELLAS Life Sciences Falls For Fourth Straight Session — What’s Driving The Sell Off? ↗
    Via Stocktwits
    News headline image
    SLS Stock In Spotlight: First AML Patient Enrolled In Phase 2 Leukemia Trial ↗
    Via Stocktwits
    News headline image
    SLS Stock Rallies Ahead Of AML Trial Readout — ‘Pharma Bro’ Martin Shkreli Says He’s Still ‘Very Bearish,’ Predicts Drug Will Fail ↗
    Via Stocktwits
    News headline image
    Dow, S&P 500, Nasdaq Futures Dip After Wall Street Rebound: Why SLS, ZVRA, RLMD, USO, CASY Are Trending After-Hours ↗
    Via Stocktwits
    Topics ETFs Government Stocks
    News headline image
    SLS Stock Falls Premarket: CEO Touts GPS Leukemia Strategy, But Investors Stay Cautious As AML Trial Nears Readout ↗
    Via Stocktwits
    News headline image
    SLS Stock Takes A Breather After Big Run: Traders Eye AML Summit Featuring Advisor For Clues On Trial Readout ↗
    Via Stocktwits
    News headline image
    SLS Stock’s Red-Hot Streak Draws Rising Short Bets — Retail Traders Are Now Betting On A Big Pharma Buyout ↗
    Via Stocktwits
    News headline image
    SLS Stock Hits Over 3-Year High As AML Drug Trial Nears Final Readout — Wall Street Sees 30% More Upside ↗
    Via Stocktwits
    News headline image
    SLS Stokes Retail Anticipation For Breakout Rally — What’s Driving The Interest? ↗
    Via Stocktwits
    Topics Death
    News headline image
    Sellas Life Sciences Draws Significant Retail Buzz As Traders Eye REGAL Phase 3 Catalyst – SLS Stock Soars 15% ↗
    Via Stocktwits
    Topics Regulatory Compliance
    News headline image
    SLS Stock In Spotlight On EU Expansion For Cancer Therapy – Retail Says Potential Catalyst For Buyout ↗
    Via Stocktwits
    News headline image
    The $170B Survival Race: Why Big Pharma is Snapping Up Late-Stage Cancer Tech
    From Equity Insider
    Via GlobeNewswire
    Top movers analysis one hour before the close of the markets on 2026-01-06: top gainers and losers in today's session. ↗
    Via Chartmill
    Let's have a look at the top gainers and losers in the middle of the day of today's session. ↗
    Via Chartmill
    News headline image
    Nasdaq, S&P 500 Futures Edge Lower Despite CES-Driven AI Optimism: Why NVDA, TSLA, AMD, AEVA, OS Are On Traders' Radar Today ↗
    Via Stocktwits
    Topics Artificial Intelligence ETFs Stocks
    News headline image
    SLS Stock Breaches $5 Level After Over 3 Years: Retail Now Eyes Buyout For As Much As $25B ↗
    Via Stocktwits
    Topics Death
    News headline image
    Why Is SLS Stock Drawing Significant Investor Attention Today? ↗
    Via Stocktwits
    Topics Death
    News headline image
    Biopharma’s Year-End Rollercoaster: Mereo Plummets 90% as BioMarin Seals $4.8 Billion Amicus Deal
    Via MarketMinute
    Topics ETFs Intellectual Property
    News headline image
    SELLAS Life Sciences Group Stock Soars As It Nears Final Analysis In Cancer Study ↗
    Via Stocktwits
    Topics Death
    News headline image
    SLS Stock Has Risen 78% In A Month — What’s The Retail Buzz About? ↗
    Via Stocktwits
    News headline image
    Precision's Payoff: Targeted Therapies Drive $131B Solid Tumor Market Surge
    From Equity Insider
    Via GlobeNewswire

    Frequently Asked Questions

    Is SELLAS Life Sciences Group, Inc. - Common Stock publicly traded?
    Yes, SELLAS Life Sciences Group, Inc. - Common Stock is publicly traded.
    What exchange does SELLAS Life Sciences Group, Inc. - Common Stock trade on?
    SELLAS Life Sciences Group, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for SELLAS Life Sciences Group, Inc. - Common Stock?
    The ticker symbol for SELLAS Life Sciences Group, Inc. - Common Stock is SLS on the Nasdaq Stock Market
    What is the current price of SELLAS Life Sciences Group, Inc. - Common Stock?
    The current price of SELLAS Life Sciences Group, Inc. - Common Stock is 12.90
    When was SELLAS Life Sciences Group, Inc. - Common Stock last traded?
    The last trade of SELLAS Life Sciences Group, Inc. - Common Stock was at 07/21/26 04:00 PM ET
    What is the market capitalization of SELLAS Life Sciences Group, Inc. - Common Stock?
    The market capitalization of SELLAS Life Sciences Group, Inc. - Common Stock is 204.77M
    How many shares of SELLAS Life Sciences Group, Inc. - Common Stock are outstanding?
    SELLAS Life Sciences Group, Inc. - Common Stock has 205M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.